Home
Conditions
Demyelinating Diseases

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 460 recruiting studies

Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies

NCT03864185

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Nagoya University Hospital Nagoya, Aich, Japan

Chiba University Hospital Chiba, Japan

Kyushu University Hospital Fukuoka, Japan

Yamaguchi University Hospital Ube, Japan

View Trial Details

Completed

Teriflunomide Observational Effectiveness Study

NCT02490982

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: CHUM Montreal, Quebec, Canada

View Trial Details

Completed

A Positive Psychology Intervention for Patients With Multiple Sclerosis

NCT03637699

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

NCT04035135

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations: National Institute of Neurosciences and Hospital Dhaka, Bangladesh

Aarhus University Hospital Aarhus, Denmark

View Trial Details

Completed

Effect of Manuel Therapy on Tonus, Proprioseption and Balance in Multiple Sclerosis

NCT04201691

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cervical Region Disorder Nos, +8 more
Locations: Hasan Kalyoncu University Gaziantep, Turkey (Türkiye)

View Trial Details

Completed

Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis

NCT04130256

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +10 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Hydroxychloroquine in Primary Progressive Multiple Sclerosis

NCT02913157

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations: MS Clinic Foothills Medical Centre Calgary, Alberta, Canada

View Trial Details

Completed

Depression and Immune Function in Multiple Sclerosis (MS)

NCT02740296

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
Locations: Charité - Universitätsmedizin Berlin Berlin, Germany

View Trial Details

Completed

Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis

NCT01272596

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: NeuroCure Clinical Reserach Center, Charité Universitaetsmedizin Berlin, Germany

View Trial Details

Completed

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

NCT00525668

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations: NeuroCure Clinical Research Center, Charite University, Berlin Berlin, Germany

Outpatient Clinic for Neuroimmunology at the ECRC, Charite University, Berlin Berlin, Germany

View Trial Details

Demyelinating Diseases

Demyelinating Diseases trial results

Related conditions